OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

1.520

-0.150 (-8.98%)

At close: Aug 31, 2026, 4:00 PM EDT

1.510

-0.010 (-0.66%)

After-hours: Aug 31, 2026, 7:30 PM EDT

OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	14.59	1.56	0.83	4.05	2.7
Short-Term Investments	6	-	-	-	-
Cash & Short-Term Investments	20.59	1.56	0.83	4.05	2.7
Cash Growth	1219.38%	88.78%	-79.56%	49.79%	-60.73%
Other Receivables	0.17	1.89	0.58	0.98	0.88
Receivables	0.17	1.89	0.58	0.98	0.88
Prepaid Expenses	0.21	0.23	0.13	0.17	0.71
Total Current Assets	20.97	3.68	1.54	5.2	4.3
Property, Plant & Equipment	0.01	0	0	0.01	0.01
Total Assets	20.98	3.68	1.54	5.2	4.3

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	7.14	7.9	6.13	2.31	0.74
Accrued Expenses	1.5	0.38	1.19	2.65	0.61
Short-Term Debt	-	-	-	2.22	-
Other Current Liabilities	0	0.95	0.1	0.07	-
Total Current Liabilities	8.64	9.23	7.42	7.26	1.35
Total Liabilities	8.64	9.23	7.42	7.26	1.35

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Additional Paid-In Capital	173.56	146.72	143.11	131.39	123.98
Retained Earnings	-151.97	-143.02	-142.52	-125.7	-112.43
Comprehensive Income & Other	-9.25	-9.24	-6.47	-7.74	-8.6
Shareholders' Equity	12.34	-5.55	-5.88	-2.05	2.95
Total Liabilities & Equity	20.98	3.68	1.54	5.2	4.3

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	-	-	-	2.22	-
Net Cash (Debt)	20.59	1.56	0.83	1.83	2.7
Net Cash Growth	1219.38%	88.78%	-54.82%	-32.23%	-60.16%
Net Cash Per Share	0.55	0.04	0.03	0.08	0.18
Filing Date Shares Outstanding	52.48	37.61	33.84	25.55	21.14
Total Common Shares Outstanding	52.48	36.02	33.34	25.52	21.14
Working Capital	12.33	-5.55	-5.88	-2.06	2.94
Book Value Per Share	0.24	-0.15	-0.18	-0.08	0.14
Tangible Book Value	12.34	-5.55	-5.88	-2.05	2.95
Tangible Book Value Per Share	0.24	-0.15	-0.18	-0.08	0.14
Machinery	0.02	0.01	0.01	0.02	0.01

SEC Filings: 10-K · 10-Q